THE PREPARATION OF CRYSTALLINE BILIRUBIN-C<sup>14</sup>

J. Donald Ostrow; Lydia Hammaker; Rudi Schmid

doi:10.1172/JCI104375

Thorndike Memorial Laboratory and the Second and Fourth (Harvard) Medical Services, Boston City Hospital, and the Department of Medicine, Harvard Medical School, Boston, Mass.

†

Postdoctoral Research Fellow, National Institutes of Health, Bethesda, Md.

Supported in part by United States Public Health Service Grant no. A-1833.

Find articles by Ostrow, J. in: PubMed | Google Scholar

Thorndike Memorial Laboratory and the Second and Fourth (Harvard) Medical Services, Boston City Hospital, and the Department of Medicine, Harvard Medical School, Boston, Mass.

†

Postdoctoral Research Fellow, National Institutes of Health, Bethesda, Md.

Supported in part by United States Public Health Service Grant no. A-1833.

Find articles by Hammaker, L. in: PubMed | Google Scholar

Thorndike Memorial Laboratory and the Second and Fourth (Harvard) Medical Services, Boston City Hospital, and the Department of Medicine, Harvard Medical School, Boston, Mass.

†

Postdoctoral Research Fellow, National Institutes of Health, Bethesda, Md.

Supported in part by United States Public Health Service Grant no. A-1833.

Find articles by Schmid, R. in: PubMed | Google Scholar

Published in Volume 40, Issue 8 on August 1, 1961
J Clin Invest. 1961;40(8):1442–1452. https://doi.org/10.1172/JCI104375.
© 1961 The American Society for Clinical Investigation

Published August 1, 1961 - Version history